Actualités Zomedica Pharmaceuticals Corp - ZOM | Actions TSX Venture Exchange

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Zomedica Pharmaceuticals Corp. Announces Second Quarter 2017 Financial Results

ANN ARBOR, Mich., Aug. 10, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM...

Zomedica Raises C$4.13 Million in First Tranche Closing of Equity Financing

ANN ARBOR, Mich., July 28, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a...

Zomedica Strengthens Executive Leadership Team

ANN ARBOR, Mich., July 10, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a...

Zomedica Pharmaceuticals Corp. to Present at The MicroCap Conference 2017 in Toronto

ANN ARBOR, Mich., June 20, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a...

Zomedica Announces 2017 Annual Meeting Results

ANN ARBOR, Mich., June 02, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica”...

Zomedica Pharmaceuticals Corp. Announces First Quarter 2017 Financial Results

ANN ARBOR, Mich., May 11, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica”...

Zomedica Announces Adoption of Advance Notice Bylaw

ANN ARBOR, Mich., April 28, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM...

Zomedica Pharmaceuticals Corp. To Present at PIONEERS 2017, Presented by Joseph Gunnar & Co.

ANN ARBOR, Mich., April 25, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a...

Zomedica Pharmaceuticals Corp. Files U.S. Registration Statement for Secondary Sales by Selling Shareholders

ANN ARBOR, Mich., April 24, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a...

Zomedica Raises C$4.35 Million in Second Tranche Closing of Equity Financing for Aggregate Proceeds of C$5.54 Million

ANN ARBOR, Mich., April 10, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a...

Zomedica Announces Ongoing Equity Financing

ANN ARBOR, Mich., March 07, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a...

Zomedica Pharmaceuticals Corp. Announces 2016 Year End Results

ANN ARBOR, Mich., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica”...

Zomedica Announces Stock Option Grant and Pending Share Issuances

ANN ARBOR, Mich., Feb. 24, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) ("Zomedica...

Zomedica Appoints Robert DiMarzo as Executive Vice President of Global Strategy

ANN ARBOR, Mich., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Zomedica Pharmaceuticals Corp (ZOM)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

ZOM Actualités

Zomedica Pharmaceuticals Corp. Announces Second Quarter 2017 Financial Results

Zomedica Raises C$4.13 Million in First Tranche Closing of Equity Financing

Zomedica Strengthens Executive Leadership Team

Zomedica Pharmaceuticals Corp. to Present at The MicroCap Conference 2017 in Toronto

Zomedica Announces 2017 Annual Meeting Results

Zomedica Pharmaceuticals Corp. Announces First Quarter 2017 Financial Results

Zomedica Announces Adoption of Advance Notice Bylaw

Zomedica Pharmaceuticals Corp. To Present at PIONEERS 2017, Presented by Joseph Gunnar & Co.

Zomedica Pharmaceuticals Corp. Files U.S. Registration Statement for Secondary Sales by Selling Shareholders

Zomedica Raises C$4.35 Million in Second Tranche Closing of Equity Financing for Aggregate Proceeds of C$5.54 Million

Zomedica Announces Ongoing Equity Financing

Zomedica Pharmaceuticals Corp. Announces 2016 Year End Results

Zomedica Announces Stock Option Grant and Pending Share Issuances

Zomedica Appoints Robert DiMarzo as Executive Vice President of Global Strategy

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Zomedica Pharmaceuticals Corp (ZOM) Actualités

Zomedica Pharmaceuticals Corp (ZOM)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

ZOM Actualités

Zomedica Pharmaceuticals Corp. Announces Second Quarter 2017 Financial Results

Zomedica Raises C$4.13 Million in First Tranche Closing of Equity Financing

Zomedica Strengthens Executive Leadership Team

Zomedica Pharmaceuticals Corp. to Present at The MicroCap Conference 2017 in Toronto

Zomedica Announces 2017 Annual Meeting Results

Zomedica Pharmaceuticals Corp. Announces First Quarter 2017 Financial Results

Zomedica Announces Adoption of Advance Notice Bylaw

Zomedica Pharmaceuticals Corp. To Present at PIONEERS 2017, Presented by Joseph Gunnar & Co.

Zomedica Pharmaceuticals Corp. Files U.S. Registration Statement for Secondary Sales by Selling Shareholders

Zomedica Raises C$4.35 Million in Second Tranche Closing of Equity Financing for Aggregate Proceeds of C$5.54 Million

Zomedica Announces Ongoing Equity Financing

Zomedica Pharmaceuticals Corp. Announces 2016 Year End Results

Zomedica Announces Stock Option Grant and Pending Share Issuances

Zomedica Appoints Robert DiMarzo as Executive Vice President of Global Strategy

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application